Learn how to navigate the medical imaging AI market, measure the potential of clinical applications, and realize their value.
This year at the RSNA annual meeting, make your way to the Blackford booth to discover how our platform can help you navigate the medical imaging AI market to identify the applications best suited to your organization, measure their potential, roll them out, and realize the value that they can deliver.
Sound too good to be true? Here’s how we do it.
First, our open vendor approach provides access to the widest selection of regulatory cleared medical imaging AI applications and allows any application on the market to be quickly added. Combined with our vast knowledge and experience, we help you navigate the market to discover the most relevant AI tools for your organization.
Then, we use evidence to help define your AI strategy and avoid time-consuming trial-and-error attempts, while reducing the internal and external costs of AI evaluation. Our platform allows you to measure the quality and performance of medical imaging AI applications – before you deploy them into your environment. Use our platform and customizable trial frameworks to automate the assessment of AI applications using your own data, measure their performance and attest that the results are accurate.
Finally, our dedicated platform helps you realize and enhance the value of medical imaging AI applications over time – delivering economies of scale to magnify the benefits. We do this by quickly and easily deploying applications, innovating the workflow integrations, orchestration and tools required, and continually measuring application performance as the AI market develops.
Watch Ben Panter, Blackford CEO, walk you through what’s holding AI back at the RSNA21 AI theatre below: